Dr Jitendra Singh announces soft launch of first indigenous antibiotic, Nafithromycin, to combat AMR The development of Nafithromycin represents 14 years of research and an investment of ₹500 crores, with clinical trials spanning…
BIRAC awards Wockhardt’s Chairman Dr Habil Khorakiwala for Nafithromycin innovation Wockhardt’s antibiotic Miqnaf receives recognition for addressing multi-drug resistant pathogens in pneumonia treatment
UNHIE, BIRAC and Social Alpha announce India accelerator platform for healthcare innovations The platform will lead to successful adoption of at least 100 Indian innovations in five years, further generating new market…
